To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Epoetin alfa
Epoetin alfa (rINN) (pronounced /ɛˈpoʊɨtɨn/) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. See alsoReferencesCategories: Drugs | Growth factors | Erythropoiesis-stimulating agents |
||||||||||||||||||||||||||||||||||||||
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Epoetin_alfa". A list of authors is available in Wikipedia. | ||||||||||||||||||||||||||||||||||||||
